182 related articles for article (PubMed ID: 32257060)
1. Neutrophil/lymphocyte ratio and lymphocyte/monocyte ratio in ulcerative colitis as non-invasive biomarkers of disease activity and severity.
Okba AM; Amin MM; Abdelmoaty AS; Ebada HE; Kamel AH; Allam AS; Sobhy OM
Auto Immun Highlights; 2019 Dec; 10(1):4. PubMed ID: 32257060
[TBL] [Abstract][Full Text] [Related]
2. Predictive Value of MHR and NLR for Ulcerative Colitis Disease Activity.
Liu T; Qin Z; Yang Z; Feng X
Int J Gen Med; 2024; 17():685-692. PubMed ID: 38435113
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential markers for ulcerative colitis: a retrospective study.
Feng W; Liu Y; Zhu L; Xu L; Shen H
BMC Gastroenterol; 2022 Nov; 22(1):485. PubMed ID: 36424535
[TBL] [Abstract][Full Text] [Related]
4. Common laboratory blood test immune panel markers are useful for grading ulcerative colitis endoscopic severity.
Cui J; Li X; Zhang Z; Gao H; Li J
BMC Gastroenterol; 2022 Dec; 22(1):540. PubMed ID: 36572872
[TBL] [Abstract][Full Text] [Related]
5. The relationship between the neutrophil-lymphocyte ratio and disease activity in patients with ulcerative colitis.
Demir AK; Demirtas A; Kaya SU; Tastan I; Butun I; Sagcan M; Sahin S; Tasliyurt T; Yilmaz A
Kaohsiung J Med Sci; 2015 Nov; 31(11):585-90. PubMed ID: 26678939
[TBL] [Abstract][Full Text] [Related]
6. Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity.
Torun S; Tunc BD; Suvak B; Yildiz H; Tas A; Sayilir A; Ozderin YO; Beyazit Y; Kayacetin E
Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):491-7. PubMed ID: 22841412
[TBL] [Abstract][Full Text] [Related]
7. Effective immune-inflammation index for ulcerative colitis and activity assessments.
Zhang MH; Wang H; Wang HG; Wen X; Yang XZ
World J Clin Cases; 2021 Jan; 9(2):334-343. PubMed ID: 33521101
[TBL] [Abstract][Full Text] [Related]
8. Predictive values of the postoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio for the diagnosis of early periprosthetic joint infections: a preliminary study.
Zhao G; Chen J; Wang J; Wang S; Xia J; Wei Y; Wu J; Huang G; Chen F; Shi J; Lyu J; Liu C; Huang X
J Orthop Surg Res; 2020 Nov; 15(1):571. PubMed ID: 33256763
[TBL] [Abstract][Full Text] [Related]
9. The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis.
Jeong Y; Jeon SR; Kim HG; Moon JR; Lee TH; Jang JY; Cho JH; Park JS; Park H; Lee KH; Kim JO; Lee JS; Ko BM; Park S
Intest Res; 2021 Jan; 19(1):62-70. PubMed ID: 32375208
[TBL] [Abstract][Full Text] [Related]
10. Platelet-to-lymphocyte Ratio and Neutrophil-to-lymphocyte Ratio Predict Mucosal Disease Severity in Ulcerative Colitis.
Akpinar MY; Ozin YO; Kaplan M; Ates I; Kalkan IH; Kilic ZMY; Yuksel M; Kayacetin E
J Med Biochem; 2018 Apr; 37(2):155-162. PubMed ID: 30581352
[TBL] [Abstract][Full Text] [Related]
11. The Relationship between C-Reactive Protein/Albumin Ratio and Disease Activity in Patients with Inflammatory Bowel Disease.
Chen YH; Wang L; Feng SY; Cai WM; Chen XF; Huang ZM
Gastroenterol Res Pract; 2020; 2020():3467419. PubMed ID: 32655630
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-to-lymphocyte ratio in inflammatory bowel disease - as a new predictor of disease severity.
Acarturk G; Acay A; Demir K; Ulu MS; Ahsen A; Yuksel S
Bratisl Lek Listy; 2015; 116(4):213-7. PubMed ID: 25773946
[TBL] [Abstract][Full Text] [Related]
13. Monocyte/High-Density Lipoprotein Ratio Is an Indicator of Activity in Patients with Ulcerative Colitis.
Yalçın MS; Yalaki S; Ölmez Ş; Taş A
Turk J Gastroenterol; 2022 Apr; 33(4):329-335. PubMed ID: 35550541
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn's disease severity.
Gao SQ; Huang LD; Dai RJ; Chen DD; Hu WJ; Shan YF
Int J Clin Exp Pathol; 2015; 8(11):14779-85. PubMed ID: 26823804
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis.
Celikbilek M; Dogan S; Ozbakır O; Zararsız G; Kücük H; Gürsoy S; Yurci A; Güven K; Yücesoy M
J Clin Lab Anal; 2013 Jan; 27(1):72-6. PubMed ID: 23292894
[TBL] [Abstract][Full Text] [Related]
16. Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease.
Xu M; Cen M; Chen X; Chen H; Liu X; Cao Q
Biomed Res Int; 2019; 2019():6517549. PubMed ID: 31950048
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Mucosal Health by NLR, CRP x NLR and MPV in Ulcerative Colitis: Can Their Availability Change According to Treatment Options?
Cifci S; Ekmen N
Cureus; 2021 Nov; 13(11):e19942. PubMed ID: 34984116
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Noninvasive Predictors of the Therapeutic Outcomes of Systemic Corticosteroid Therapy in Ulcerative Colitis.
Endo K; Satoh T; Yoshino Y; Kondo S; Kawakami Y; Katayama T; Sasaki Y; Takasu A; Kogure T; Hirota M; Meguro T; Satoh K
Inflamm Intest Dis; 2021 Dec; 6(4):218-224. PubMed ID: 35083287
[TBL] [Abstract][Full Text] [Related]
19. Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity.
Cherfane CE; Gessel L; Cirillo D; Zimmerman MB; Polyak S
Inflamm Bowel Dis; 2015 Aug; 21(8):1769-75. PubMed ID: 25993688
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil/lymphocyte and platelet/lymphocyte ratios as potential markers of disease activity in patients with Ankylosing spondylitis: a case-control study.
Al-Osami MH; Awadh NI; Khalid KB; Awadh AI
Adv Rheumatol; 2020 Jan; 60(1):13. PubMed ID: 32000859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
